Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Overexpression of PKMYT1 associated with poor prognosis and immune infiltration may serve as a target in triple-negative breast cancer

30 Jan 2023

Abstract excerpt

Breast cancer (BC) is one of the most common malignancies among women worldwide. It is necessary to search for improvement in diagnosis and treatment methods to improve the prognosis. Protein kinase, membrane associated tyrosine/threonine 1 (PKMYT1), a member of the Wee family of protein kinases, has been studied in some tumors except BC. This study has explored that PKMYT1 functional role by bioinformatics...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer Genomics and Diagnostics
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36793346
DOI: 10.3389/fonc.2022.1002186

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Overexpression of PKMYT1 associated with poor prognosis and immune infiltration may serve as a target in triple-negative breast cancerPMID 36793346Read ↗

Definition of PKC-α, CDK6, and MET as Therapeutic Targets in Triple-Negative Breast CancerSemantic proximity Read ↗

Integrative Analysis of the Expression Levels and Prognostic Values for NEK Family Members in Breast CancerSemantic proximity Read ↗

Systematic Analysis Uncovers Associations of PGK1 with Prognosis and Immunological Characteristics in Breast Cancer.Semantic proximity Read ↗

Exploration of prognostic value and underlying mechanism of P2RY14 in triple negative breast cancer by multi-omicsSemantic proximity Read ↗

The DNA damage repair-related gene PKMYT1 is a potential biomarker in various malignanciesSemantic proximity Read ↗

An insight into the development of triple-negative breast cancer at transcriptome level based on single-cell sequencing technologySemantic proximity Read ↗

Identification of biomarker associated with Trop2 in breast cancer: implication for targeted therapySemantic proximity Read ↗

PKMYT1, exacerbating the progression of clear cell renal cell carcinoma, is implied as a biomarker for the diagnosis and prognosisSemantic proximity Read ↗

Kinome expression profiling and prognosis of basal breast cancersSemantic proximity Read ↗

WITHDRAWN: Identifying and validating the prognosis and potential significance of Mitophagy related genes in breast cancerSemantic proximity Read ↗

Mitochondrial DNA methylation is a predictor of immunotherapy response and prognosis in breast cancer: scRNA-seq and bulk-seq data insightsSemantic proximity Read ↗

Unveiling promising breast cancer biomarkers: an integrative approach combining bioinformatics analysis and experimental verificationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.